Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00177
|
|||||
Drug Name |
Cetirizine
|
|||||
Synonyms |
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid; (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid; Cetiderm; Cetiderm (TN); Cetirizin; Cetirizina; Cetirizina [Spanish]; Cetirizine (INN); Cetirizine [INN:BAN]; Cetirizinum; Cetirizinum [Latin]; Cetrizine Hcl; Cetryn; Hitrizin Film Tablet; P-071; Reactine (TN); Setir; Virlix; Ziptek; Zirtek; Zyrlex; Zyrtec (TN); [(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Allergic rhinitis [ICD11: CA08.0] | Approved | [1] | |||
Therapeutic Class |
Antiallergic Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C21H25ClN2O3
|
|||||
Canonical SMILES |
C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
|
|||||
InChI |
InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)
|
|||||
InChIKey |
ZKLPARSLTMPFCP-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 83881-51-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 388.9 | Topological Polar Surface Area | 53 | ||
Heavy Atom Count | 27 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
1.7
|
|||||
PubChem CID | ||||||
PubChem SID |
103266652
, 104170194
, 104301286
, 108136263
, 11466531
, 11467651
, 11486082
, 11501857
, 117611598
, 117843325
, 121362416
, 124526347
, 125324646
, 125339821
, 125544920
, 125822846
, 126525325
, 126582564
, 126619301
, 14756386
, 29221835
, 46508368
, 47359454
, 47583265
, 47953980
, 48179259
, 48403972
, 48415747
, 49698526
, 49846704
, 49861380
, 50112918
, 50112919
, 50112920
, 50276923
, 51091966
, 5658851
, 57321395
, 57581408
, 7978899
, 81041207
, 8151737
, 85209379
, 853774
, 85788875
, 90341832
, 92290962
, 92721266
, 93624540
, 9980
|
|||||
ChEBI ID |
ChEBI:3561
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Cetirizine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction. Chirality. 2010 Jul;22(7):684-92. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.